• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Gilead Sciences Inc. (Nasdaq: GILD)

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. *

 

	Start	1987-06-22 established
	Group	Gilead Sciences (Group)
	Industry	biopharmaceutical
	Industry 2	virostatic agent
	Street	333 Lakeside Drive
	City	94404 Foster City, CA
		Address record changed: 2015-04-24
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	4,230,045,000 (revenues, total, consolidated (2007) 2007-12-31)
	Profit	1,615,298,000 (2007-12-31)
	Cash	2,722,422,000 (2007-12-31)
		* Document for �About Section�:
		Record changed: 2019-11-27

Advertisement

More documents for Gilead Sciences (Group)

• [1] Gilead Sciences, Inc.. (7/19/19). "Press Release: Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis". Foster City, CA....
• [2] Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
• [3] Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd....
• [4] Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
• [5] Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA....
• [6] Hookipa Biotech AG. (6/5/18). "Press Release: Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B". Vienna & Foster City, CA....
• [7] Cell Medica Ltd.. (8/1/18). "Press Release: Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation". London & Houston, TX....
• [8] Gilead Sciences, Inc.. (10/3/17). "Press Release: Gilead Sciences Completes Acquisition of Kite Pharma, Inc.". Foster City, CA....
• [9] Medigene AG. (8/30/17). "Press Release: Medigene Presents Automated Platform for TCR Identification at CAR-TCR Summit". Planegg....
• [10] Kite Pharma, Inc.. (8/28/17). "Press Release: Gilead Sciences to Acquire Kite Pharma for $11.9 Billion. Immediately Positions Gilead as a Leader in Cell Therapy". Foster City, CA & Santa Monica, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.